600165 *ST寧科生物
按盤價 
2.770 +0.130 (+4.924%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 300.360 | -141.042 | -31.724 | -19.240 | 2.250 |
| 總資產報酬率 ROA (%) | -18.550 | -14.906 | -6.409 | -5.002 | 0.749 |
| 投入資產回報率 ROIC (%) | -39.532 | -24.808 | -9.274 | -6.613 | 0.774 | 邊際利潤分析 |
| 銷售毛利率 (%) | -0.349 | -34.621 | 0.084 | -32.934 | 9.223 |
| 營業利潤率 (%) | -261.941 | -172.692 | -39.561 | -74.861 | 2.226 |
| 息稅前利潤/營業總收入 (%) | -209.728 | -130.799 | -25.362 | -62.638 | 36.110 |
| 淨利潤/營業總收入 (%) | -270.382 | -180.357 | -40.912 | -76.166 | 19.478 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 33.755 | 60.907 | 92.316 | 93.760 | -206.382 |
| 價值變動淨收益/利潤總額(%) | 49.435 | -6.631 | -14.389 | -21.262 | 208.018 |
| 營業外收支淨額/利潤總額(%) | 3.081 | 4.302 | 1.567 | 0.459 | 86.789 | 償債能力分析 |
| 流動比率 (X) | 0.154 | 0.106 | 0.153 | 0.289 | 0.630 |
| 速動比率 (X) | 0.086 | 0.055 | 0.087 | 0.155 | 0.560 |
| 資產負債率 (%) | 110.455 | 89.665 | 75.079 | 67.822 | 61.827 |
| 帶息債務/全部投入資本 (%) | 80.543 | 59.728 | 48.212 | 40.677 | -- |
| 股東權益/帶息債務 (%) | -65.204 | 10.189 | 54.847 | 77.844 | 88.936 |
| 股東權益/負債合計 (%) | -17.121 | 3.739 | 22.748 | 34.358 | 46.377 |
| 利息保障倍數 (X) | -3.464 | -2.634 | -1.710 | -4.984 | 1.875 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 70.992 | 56.537 | 15.543 | 47.113 | 0.000 |
| 存貨周轉天數 (天) | 163.571 | 95.595 | 75.511 | 122.267 | 0.000 |
| 備註： | 即時報價更新時間為 27/01/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
